Why the study?
The study of interventions for non-ST-segment elevation myocardial infarction lacks a reproducible preclinical model, as existing animal models mimic only full-thickness STEMI infarcts.
A novel ovine model of NSTEMI successfully reproduces post-ischaemic extracellular matrix adverse remodelling, identifying specific molecular targets for future pharmacological interventions.
Answers are grounded in this paper and cite their sources.
Provides a reproducible large-animal NSTEMI model for remodelling studies; hypothesis-generating with no immediate clinical implications.
The rising incidence of non-ST-segment elevation myocardial infarction (NSTEMI) and associated long-term high mortality constitutes an urgent clinical issue. Unfortunately, the study of possible interventions to treat this pathology lacks a reproducible pre-clinical model. Indeed, currently adopted small and large animal models of MI mimic only full-thickness, ST-segment-elevation (STEMI) infarcts, and hence cater only for investigation into therapeutics and interventions directed at this subset of MI. Thus, we developed an ovine model of NSTEMI by ligating the myocardial muscle at precise intervals parallel to the left anterior descending coronary artery. After validating the presented model both by histology and functional analysis with clinical data, further omics analyses highlighted the distinctive features of post-NSTEMI tissue remodelling. Here, by looking at the transcriptome and proteome-derived pathways emerging at acute (7 days) and late (28 days) post-surgery timepoints, we discovered specific alterations in cardiac post-ischaemic extracellular matrix (ECM). Together with the rise of well-known markers of inflammation and fibrosis, NSTEMI ischaemic regions showed distinctive patterns in the expression of complex N-glycans and glycosaminoglycans in cellular membranes and ECM. Identifying such changes in molecular moieties accessible to infusible and intra-myocardial injectable drugs sheds light on the development of targeted pharmacological solutions to contrast adverse fibrotic remodelling.
No takes yet. Share an insight, caveat, or question.
Contessotto et al. (2022) studied Non-ST-segment elevation myocardial infarction (NSTEMI) (n=21). Multiple ligations lateral and parallel to the left anterior descending coronary artery vs. Pre-MI baseline / Healthy tissue was evaluated on Ejection fraction reduction at 28 days post-NSTEMI (p=0.009).
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: